Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 980 | 2 | NICORANDIL//CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS | 10891 |
| 21016 | 1 | CLINICAL TRIALS CRITERIA//SALT SENSITIVITY THRESHOLD//SPRINT STUDY GRP | 459 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CLINICAL TRIALS CRITERIA | authKW | 137326 | 0% | 100% | 2 |
| 2 | SALT SENSITIVITY THRESHOLD | authKW | 137326 | 0% | 100% | 2 |
| 3 | SPRINT STUDY GRP | address | 137326 | 0% | 100% | 2 |
| 4 | CALCIUM CHANNEL BLOCKERS | authKW | 113005 | 14% | 3% | 63 |
| 5 | 24 HOUR EFFICACY IN REDUCTION OF BLOOD PRESSURE | authKW | 68663 | 0% | 100% | 1 |
| 6 | 3 FMPPOB 3333 | address | 68663 | 0% | 100% | 1 |
| 7 | ACCIDENTAL AND PROGRAMMED CELL DEATH | authKW | 68663 | 0% | 100% | 1 |
| 8 | AMBULATORY PRESCRIPTIONS | authKW | 68663 | 0% | 100% | 1 |
| 9 | AMDODIPINE | authKW | 68663 | 0% | 100% | 1 |
| 10 | ANTI ANGINAL EFFECTS | authKW | 68663 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 3701 | 36% | 0% | 163 |
| 2 | Peripheral Vascular Diseases | 2265 | 21% | 0% | 96 |
| 3 | Medicine, General & Internal | 900 | 21% | 0% | 98 |
| 4 | Pharmacology & Pharmacy | 447 | 20% | 0% | 92 |
| 5 | Primary Health Care | 95 | 2% | 0% | 7 |
| 6 | Public, Environmental & Occupational Health | 72 | 7% | 0% | 30 |
| 7 | Toxicology | 17 | 3% | 0% | 12 |
| 8 | Geriatrics & Gerontology | 16 | 1% | 0% | 6 |
| 9 | Oncology | 12 | 5% | 0% | 23 |
| 10 | Health Care Sciences & Services | 7 | 1% | 0% | 6 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | SPRINT STUDY GRP | 137326 | 0% | 100% | 2 |
| 2 | 3 FMPPOB 3333 | 68663 | 0% | 100% | 1 |
| 3 | CARDIOL L3104 | 68663 | 0% | 100% | 1 |
| 4 | CARDIOPULM CLIN INVEST DEV | 68663 | 0% | 100% | 1 |
| 5 | CARDIOVASC PULM MEMBRANE BIOPHYS | 68663 | 0% | 100% | 1 |
| 6 | CLIN EPIDEMTOL BIOSTAT | 68663 | 0% | 100% | 1 |
| 7 | CLIN ROADM TEAM | 68663 | 0% | 100% | 1 |
| 8 | GEREPT EPIDEMIOL POPULAT BOURGOGNE | 68663 | 0% | 100% | 1 |
| 9 | GLOBAL PHAMACOEPIDEMIOL | 68663 | 0% | 100% | 1 |
| 10 | MED FDN CLIN LAVORO | 68663 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CARDIOVASCULAR DRUGS AND THERAPY | 7836 | 3% | 1% | 15 |
| 2 | AMERICAN JOURNAL OF HYPERTENSION | 5500 | 5% | 0% | 22 |
| 3 | JOURNAL OF HUMAN HYPERTENSION | 4112 | 3% | 0% | 15 |
| 4 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4094 | 3% | 0% | 12 |
| 5 | EUROPEAN HEART JOURNAL | 3508 | 5% | 0% | 23 |
| 6 | JOURNAL OF HYPERTENSION | 2511 | 4% | 0% | 19 |
| 7 | CLINICAL TRIALS AND META-ANALYSIS | 2450 | 0% | 4% | 1 |
| 8 | AMERICAN JOURNAL OF CARDIOLOGY | 2262 | 7% | 0% | 30 |
| 9 | KARDIOLOGIYA | 1734 | 3% | 0% | 13 |
| 10 | FORMULARY | 1024 | 1% | 1% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |